A significant accumulation of EGFR was observed in the BAF.A1-treated cells compared with EGF alone (Figure 7E,F), indicating that BAF.A1 reverses EGF-induced EGFR degradation in CTRL and in DM1 cells. Here, EGFR is linked to myotonic dystrophy type 1.